Universal Biosensors, Inc.

ASX:UBI Voorraadrapport

Marktkapitalisatie: AU$37.3m

Universal Biosensors Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Universal Biosensors's earnings have been declining at an average annual rate of -18.7%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 2.6% per year.

Belangrijke informatie

-18.7%

Groei van de winst

-14.0%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie5.8%
Inkomstengroei-2.6%
Rendement op eigen vermogen-59.3%
Nettomarge-175.0%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

Nov 09
We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

May 03
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

Jan 12
We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Oct 10
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In Growth

Apr 28
Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In Growth

We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

May 13
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?

Feb 24
Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?

We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

Jan 20
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For More

Dec 15
The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For More

Opbrengsten en kosten

Hoe Universal Biosensors geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

ASX:UBI Opbrengsten, kosten en inkomsten (AUD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 247-12154
30 Jun 247-12164
31 Mar 247-6163
31 Dec 237-7155
30 Sep 235-18157
30 Jun 234-20149
31 Mar 234-261310
31 Dec 225-271112
30 Sep 225-191013
30 Jun 225-16812
31 Mar 226-14711
31 Dec 216-1169
30 Sep 216-766
30 Jun 216-665
31 Mar 214-865
31 Dec 203-865
30 Sep 203-765
30 Jun 204-665
31 Mar 206-465
31 Dec 197-576
30 Sep 1914-886
30 Jun 19603588
31 Mar 196435710
31 Dec 186938712
30 Sep 186539713
30 Jun 1824-4813
31 Mar 1825-3713
31 Dec 1725-1711
30 Sep 17266711
30 Jun 17235711
31 Mar 17225611
31 Dec 16191613
30 Sep 1617-6614
30 Jun 1620-4715
31 Mar 1619-5718
31 Dec 1517-7717
30 Sep 1518-5618
30 Jun 1514-6618
31 Mar 1511-9617
31 Dec 1410-9617
30 Sep 148-12618
30 Jun 148-11617
31 Mar 1412-11616
31 Dec 1315-12615

Kwaliteitswinsten: UBI is currently unprofitable.

Groeiende winstmarge: UBI is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: UBI is unprofitable, and losses have increased over the past 5 years at a rate of 18.7% per year.

Versnelling van de groei: Unable to compare UBI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: UBI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Rendement op eigen vermogen

Hoge ROE: UBI has a negative Return on Equity (-59.28%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden